CD19 and acute lymphoblastic leukemia: In iALL, blasts are predominantly CD19+CD10−, often with aberrant myeloid cell surface markers suggestive of an immature B-progenitor, as opposed to a CD19+CD10+ Pre-B phenotype in childhood-ALL (18, 96).